SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-02-05 20:35
Tx date 2026-02-03 		$LSL
LSL Pharma Group Inc. 		Laflamme, Louis
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$15,600
+30,000 vol
$0.52 each 		280,000
Filed 2026-02-05 20:32
Tx date 2026-02-03 		$LSL
LSL Pharma Group Inc. 		Laflamme, Louis
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-92,500
-250,000 vol
$0.37 each 		250,000
Filed 2026-02-04 14:40
Tx date 2023-02-22 		$LSL
LSL Pharma Group Inc. 		Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		350,000
Filed 2026-02-04 14:37
Tx date 2023-02-22 		$LSL
LSL Pharma Group Inc. 		Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		2,500,000
Filed 2026-02-04 10:02
Tx date 2026-02-03 		$LSL
LSL Pharma Group Inc. 		Paradis, Mario
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+190,000 vol 		355,000
Filed 2026-02-04 09:34
Tx date 2026-02-03 		$LSL
LSL Pharma Group Inc. 		Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+165,000 vol 		1,645,270
Filed 2026-02-04 08:47
Tx date 2026-02-03 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+160,000 vol 		160,000
Filed 2026-02-04 08:47
Tx date 2025-10-16 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-02-04 08:42
Tx date 2026-02-03 		$LSL
LSL Pharma Group Inc. 		Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+190,000 vol 		470,000
Filed 2023-03-03 23:58
Tx date 2023-02-22 		$LSL
LSL Pharma Group Inc. 		Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-03 23:48
Tx date 2023-02-22 		$LSL
LSL Pharma Group Inc. 		Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-12-23 12:02
Tx date 2025-12-23 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Convertible Debentures Dec 2025, 10%, 4yrs, conv. ($0.45)
16 - Acquisition or disposition under a prospectus exemption
+$4,000,000 vol 		$4,000,000
Filed 2025-12-23 11:24
Tx date 2025-12-23 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Convertible Debentures Dec 2025, 10%, 4yrs, conv. ($0.45)
16 - Acquisition or disposition under a prospectus exemption 		$
+$4,000,000 vol
$1,000 each 		$4,000,000
Filed 2025-12-23 11:24
Tx date 2025-12-23 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Convertible Debentures Dec 2025, 10%, 4yrs, conv. ($0.45)
16 - Acquisition or disposition under a prospectus exemption 		$
+$4,000,000 vol
$1,000 each
Filed 2025-12-23 10:50
Tx date 2025-10-16 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Convertible Debentures Dec 2025, 10%, 4yrs
00 - Opening Balance-Initial SEDI Report
Filed 2025-10-23 16:09
Tx date 2025-10-16 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		6,250,000
Filed 2025-10-17 13:52
Tx date 2025-10-16 		$LSL
LSL Pharma Group Inc. 		Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report 		6,250,000
Filed 2025-09-02 17:12
Tx date 2025-08-29 		$LSL
LSL Pharma Group Inc. 		Paradis, Mario
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$87,500
+125,000 vol
$0.70 each 		375,000
Filed 2025-09-02 17:11
Tx date 2025-08-29 		$LSL
LSL Pharma Group Inc. 		Paradis, Mario
4 - Director of Issuer
Direct Ownership
Common Shares catégorie A
16 - Acquisition or disposition under a prospectus exemption 		$50,000
+125,000 vol
$0.40 each 		375,000
Filed 2025-09-02 10:47
Tx date 2025-08-29 		$LSL
LSL Pharma Group Inc. 		Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+187,500 vol 		259,000